article
Jim Shanahan from SynDevRx explains why metabo-oncology treatment modalities could…
8 February 2021 | By Victoria Rees (Drug Target Review)
Jim Shanahan from SynDevRx explains why metabo-oncology treatment modalities could be the answer to a rise in metabolic disorders and cancers.